Austin Private Wealth’s CorMedix CRMD Stock Holding History

Austin Private Wealth’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,480	Closed	-$48K	–	164
2021 Q4	$48K	Hold	10,480	–	–	0.01%	159
2021 Q3	$49K	Hold	10,480	–	–	0.01%	140
2021 Q2	$72K	Hold	10,480	–	–	0.02%	130
2021 Q1	$105K	Hold	10,480	–	–	0.03%	111
2020 Q4	$78K	Hold	10,480	–	–	0.02%	110
2020 Q3	$63K	Hold	10,480	–	–	0.02%	92
2020 Q2	$66K	Hold	10,480	–	–	0.03%	88
2020 Q1	$38K	Hold	10,480	–	–	0.02%	74
2019 Q4	$76K	Buy	+10,480	New	+$64K	0.04%	85

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Austin Private Wealth's CRMD Position: Q1 2022 in Review

Austin Private Wealth sold out of CorMedix (CRMD) in Q1 2022, closing a stake of 10,480 shares — an estimated $48K sold.

Austin Private Wealth first reported a position in CRMD in Q4 2019 and held it in 9 quarters. The position peaked at $105K in Q1 2021. 85 funds tracked by Wall St. Rank hold CRMD as of Q1 2022.

Austin Private Wealth reported no remaining CorMedix position as of Q1 2022 after selling out during the quarter.
Austin Private Wealth sold 10,480 CorMedix shares in Q1 2022, an estimated $48K.
Austin Private Wealth first reported a position in CorMedix in Q4 2019 and held it in 9 quarters.
Austin Private Wealth's CorMedix position peaked at $105K in Q1 2021.
85 funds tracked by Wall St. Rank held CorMedix as of Q1 2022.

Based on Austin Private Wealth's 13F filing for Q1 2022, filed 6 May 2022.